New high flow Bormed™ HE9601-PH high density polyethylene (HDPE) from Borealis and Borouge, the world’s leading providers of innovative, value-creating plastics solutions, creates productivity improvements for converters in the healthcare market without compromising the performance of medical devices and pharmaceutical and diagnostic packaging.
With a melt flow rate (MFR) of 31, Bormed HE9601-PH delivers a flow rate improvement of up to 2.5 times that of comparable alternatives. This major enhancement enables higher speed injection moulding of applications ranging from two-part syringe plungers to caps and closures.
In addition to the potential for faster production and increased throughput, the higher flow allows for operation at decreased pressure and temperature. This lowers both energy and mould maintenance requirements and gives a cost advantage.
Bormed HE9601-PH simplifies the injection moulding process by enabling easier moulding, in particular of components with complex design parameters or longer flow lengths.
Bormed HE9601-PH offers the full range of benefits valued by converters for highly-demanding medical applications. These include high stiffness, chemical inertness and high chemical resistance, excellent barrier performance and impermeability to water vapour. Bormed HE9601-PH can be sterilised using all common techniques such as EtO and radiation.
The new grade is the latest addition to the Bormed family of polyethylene and polypropylene products for the healthcare market delivered globally by Borealis and Borouge, leading providers of chemical and innovative plastics solutions.
The dedicated product range combines regulatory compliance and full traceability with special production and quality control measures, technical support, and the assurance of supply, to meet the strict demands of healthcare original equipment manufacturers (OEMs). Bormed HE9601-PH complies with European and US Pharmacopeia and is Drug Master File registered.
“Borealis and Borouge’s continuous improvement of healthcare-dedicated materials and long-term commitment to the market through product availability, allow us to bring peace of mind to the industry’s value chain, from converter to end-user,” comments Max Wachholder, Borealis Marketing Manager for Healthcare. “We are delighted to launch Bormed HE9601-PH with its immediate productivity benefits for the healthcare market.”
Bormed ™ – because we care
With more than 30 years of experience in serving the healthcare market, Borealis understands the industry’s need for reliable global material suppliers and is continually strengthening its support.
Borealis offers dedicated global products, security of supply, innovation and technical support for the specialised and strict requirements of these customers. Its ever-expanding range of dedicated Bormed™ polyolefins focuses on high quality and long-term commitment which is anchored by our financially strong ownership. Polypropylene and polyethylene innovations provide superior technical performance to meet the lightweight, aesthetic and processing and consumer convenience-related demands of the fast-growing medical devices and pharmaceutical and diagnostic packaging markets, independent of conversion technology or polymer type.
The Bormed product range responds to the challenging service requirements of the healthcare industry. Regulatory compliance and special production and quality control procedures are some of the elements that ensure stability, reliability, traceability, consistency and continuity. This gives customers around the world confidence in their use of Bormed materials to advance their application.
About Borealis and Borouge
Borealis is a leading provider of chemical and innovative plastics solutions that create value for society. With sales of EUR 6.3 billion in 2010, customers in over 120 countries, and 5,100 employees worldwide, Borealis is owned 64% by the International Petroleum Investment Company (IPIC) of Abu Dhabi and 36% by OMV, the leading energy group in the European growth belt. Borealis is headquartered in Vienna, Austria, and has production locations, innovation centres and customer service centres across Europe and the Americas.
Through Borouge, a joint venture between Borealis and the Abu Dhabi National Oil Company (ADNOC), one of the world’s major oil and gas companies, the company’s footprint reaches out to the Middle East, Asia Pacific, the Indian sub-continent and Africa. Established in 1998, Borouge employs approximately 1,600 people, has customers in more than 50 countries and its headquarters are in Abu Dhabi in the UAE and Singapore.
Building on Borealis’ unique Borstar® technology and their experience in polyolefins of more than 50 years, Borealis and Borouge provide innovative, value creating plastics solutions for the infrastructure (pipe systems and power and communication cables), automotive and advanced packaging markets. In addition, Borealis offers a wide range of base chemicals from melamine and plant nutrients to phenol and acetone.
Today, Borealis and Borouge have a manufacturing capacity of over 5.4 million tonnes of polyolefins (polyethylene and polypropylene) per year of which 26% are the result of a recently completed capacity expansion in Abu Dhabi. An additional 2.5 million tonnes per year is scheduled for completion by mid-2014, creating the world’s largest integrated polyolefins plant. The companies continue to invest to ensure that their customers throughout the value chain, around the world, can always rely on superior products and security of supply.
Borouge (borouge.com) and Borealis (borealisgroup.com) are committed to the principles of Responsible Care® and proactively contribute to addressing the world’s water and sanitation challenges through their Water for the World™ (waterfortheworld.net) initiative.
Bormed and Water for the World are trademarks of the Borealis group.